Dr. Knudsen Discusses the Rationale of the DALIAH Trial in MPNsByTrine Alma Knudsen, MD, PhDJuly 9th 2018Trine Alma Knudsen, MD, PhD student, Department of Haematology, Zealand University Hospital, Roskilde, Denmark, discusses the rationale of the DALIAH trial in patients with myeloproliferative neoplasms.